MedPath

Effect of Ageing on Airway Remodeling

Not Applicable
Terminated
Conditions
Aging
Interventions
Other: EFR and TDM
Registration Number
NCT01230879
Lead Sponsor
University Hospital, Montpellier
Brief Summary

The aim of the study is to investigate the relationship between aging and morphological changes in the lung. 120 consecutive healthy volunteers over 60 years will be enrolled for this trial.

Detailed Description

Chest multidetector CT without injection and spirometry data will be obtained from a multicentric sample of individuals between 60 and 95 years of ageExclusion criteria were current smoking, history of smoking within the past 10 years, any known chronic or acute pulmonary disease. Individuals treated with Amiodarone, Bleomycin or methotrexate were excludedOutcome

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
101
Inclusion Criteria
  • People from 60 to 95 years old free from chest disease or history of chest disease
Exclusion Criteria
  • Chronic cough
  • Dyspnea
  • Sinonasal or chest infection during enrollment
  • Myocardial infarction.
  • Current smoker or past smoker with more than 10 pack year intoxication

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
71 - 80 years oldEFR and TDMEFR and TDM
81 - 95 years oldEFR and TDMEFR and TDM
60 - 70 years oldEFR and TDMEFR and TDM
Primary Outcome Measures
NameTimeMethod
Bronchial wall thickness1 day

Bronchial wall thickness and remodeling associated with aging

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Montpellier Hospital

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath